A recent study has reported that Pembrolizumab combined with microRNA-20b-5p enhances tumor cell radiosensitivity by impeding the PD-L1/PD-1 axis, thereby suppressing tumor cell growth in vivo [26]. Here, CD274 is linked to neoplasm.